Artificial Intelligence (AI) is revolutionizing clinical trials by efficiently matching patients with trials tailored to their unique medical profiles. AI platforms developed by companies like Klineo and PatLynk streamline the recruitment process,
Avanos Medical reported approximately $180 million in fourth-quarter sales, with a 5% organic increase, highlighting the strength of its enteral feeding franchise. The company
Alphabet Inc. (NASDAQ:GOOGL) continues to captivate investors, ranking high on Bourgeon Capital Management’s list of favored stocks. Bourgeon Capital, led by John Zaro, maintains
The revamped 2025 Xpeng G6, a coupe-SUV hybrid, launches on February 28 with 81 significant upgrades. The “Galaxy Light Wing” LED strip and repositioned
Magnite’s Connected TV (CTV) segment experienced a substantial 23% year-over-year growth in Q4, surpassing forecasts and signaling strong strategic investments. Despite a slight 1%
Palantir Technologies faces financial vulnerability due to heavy reliance on U.S. government contracts amidst possible budget cuts. Investor concerns rise with speculations of federal
NVIDIA’s DLSS 4 plugins for Unreal Engine 5 introduce groundbreaking AI upscaling to enhance gaming visual fidelity. Technologies like Multi Frame Generation and Ray
Sarepta Therapeutics achieved a significant milestone with the FDA approval of ELEVIDYS, a groundbreaking therapy for Duchenne muscular dystrophy. The success of ELEVIDYS marked
Nvidia faces intense investor scrutiny as earnings season approaches, with a potential dramatic shift in share prices. The options market predicts significant price fluctuation,
Salesforce, under CEO Marc Benioff, achieved significant growth and innovation, marking a successful chapter in its history. The fourth quarter, known as the “Quarter
KULR Technology Group specializes in advanced thermal management solutions crucial for industries like electric vehicles and aerospace. KULR’s focus on sustainable and energy-efficient technologies